BioCentury
ARTICLE | Financial News

Biovail off on downgrade

October 3, 2000 7:00 AM UTC

Biovail (BVF; TSE:BVF) slid $19.438 (22 percent) to $67.438 on 3.8 million shares on Tuesday after Banc of America Securities analyst Jerry Treppel downgraded the generics and drug delivery company to...